Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.55968 | 23 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.46742 | 20 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.47313 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.3923 | 18 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39519 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.53025 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.56684 | 23 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.44792 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.42983 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.4556 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.46901 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43456 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.56265 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.46319 | 20 |